Results 91 to 100 of about 225,446 (206)

Orbital Decompression for Graves\u27 Ophthalmopathy

, 1999
Graves\u27 disease is an autoimmune process with an antibody directed against the TSH receptor. Graves\u27 hyperthyroidism results from stimulation of the thyrotropin receptors on thyroid follicular cells by circulating thyrotropin receptor antibodies ...
James A. Garrity
core  

Carotid cavernous fistula in a patient with Graves' ophthalmopathy

, 2003
The clinical manifestations of carotid cavernous fistula, an abnormal arteriovenous connection between the cavernous sinus and the carotid artery, can closely mimic the cardinal signs of Graves' ophthalmopathy, an inflammatory disorder of the orbit ...
Bracco S., Loffredo A., Talidis F., Cerase A., Polito E., Pichierri P., Loré F.   +6 more
core   +1 more source

GAMBARAN KLINIS GRAVES OPHTHALMOPATHY DAN HUBUNGAN ANTARA DERAJAT GRAVES OPHTHALMOPATHY DENGAN LAMA MENDERITA HIPERTIROID DI POLIKLINIK ENDOKRIN RSUDZA BANDA ACEH

Graves ophthalmopathy merupakan penyakit autoimun dan imunitas seseorang berbeda sesuai dengan usia, jenis kelamin, dan lama paparan terhadap antigen.
Cut intan Hidayah
core  

Plasma exchange therapy for severe graves' ophthalmopathy

, 1986
In the present studies, the authors report on the treatment of nine Graves' disease patients with severe ophthalmopathy by use of intensive plasma exchange followed by immunosuppression (during three to six months). Results of treatment were evaluated by
Winand, René, Schrooyen, Marc, Glinoer, Daniel   +2 more
core   +1 more source

Antioxidant agents in the treatment of Graves' ophthalmopathy

, 2000
PURPOSE: To report the effect of antioxidant agents in the treatment of mild and moderately severe Graves' ophthalmopathy. METHODS: Prospective, nonrandomized, comparative study performed at a referral center.
Bouzas, E.A., Koutras, D.A., Mastorakos, G., Karadimas, P.   +3 more
core   +1 more source

Orbital radiotherapy for Graves' ophthalmopathy

, 2002
Orbital radiotherapy is a well-established method of treatment for severe Graves' ophthalmopathy because of its anti-inflammatory and locally immunosuppressive effects. It has been used for 60 years.
PINCHERA A., ROCCHI R, MARCOCCI C, TANDA, MARIA LAURA PIERA, BARBESINO G, BARTALENA, LUIGI, MAZZI B   +6 more
core   +1 more source

Prevalence of Graves ophthalmopathy among patients with thyroid disease

Philippine Journal of Ophthalmology, 2010
Objective: This study determined the prevalence of Graves ophthalmopathy among thyroid-disease patients at a tertiary government hospital. Methods: Patients with thyroid disease seen at a tertiary hospital from February to September 2007 were enrolled.
Erwin D. Palisoc, MD, Evelyn S. Morabe, MD, Paulo Ma. N. Pagkatipunan, MD   +2 more
doaj  

Increased retinal blood flow in patients with active Graves' ophthalmopathy

, 2007
PURPOSE: To investigate retinal blood flow by Heidelberg retina flowmeter in patients with active Graves' ophthalmopathy. MATERIALS AND METHODS: Thirty patients with active Graves' ophthalmopathy in euthyroid state and thirty normal controls were ...
Costagliola, Ciro, CAMPA, Claudio, INCORVAIA, Carlo, SEBASTIANI, Adolfo, PERRI, Paolo, Costagliola C., D'ANGELO, Sergio   +6 more
core   +1 more source

Graves' ophthalmopathy

Swiss Medical Weekly, 2002
Swiss Medical Weekly
doaj   +1 more source

Steroid Treatment Focused Management of Graves’ Ophthalmopathy

Acta Medica Bulgarica
Graves' disease (GD) is an autoimmune disease that affects the thyroid and the eyes. Graves' ophthalmopathy (GO), an autoimmune disease, usually appears 18 months after GD diagnosis.
Condeng Y. H., Umar H., Aman A. M., Rasyid H., Bakri S., Iskandar H.   +5 more
doaj   +1 more source